logo

For the Inventor, By the Inventor

Lyon, France

Nabil Farah

This inventor holds 5 USPTO granted patents. Top assignees: Gattefosse S.a., Other. Active years: 2000-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nabil Farah. Retrieved from https://idiyas.com/inventor/nabil-farah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 216(Granted Patents)


Location History:

  • Lyon, FR (2001)
  • Lyons, FR (2000 - 2002)

Company Filing History:

goldMedal3 out of 9 
 
Gattefosse S.a.
 patents
silverMedal2 out of 834,513 
Other
 patents

Years Active: 2000-2002

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6379700 - Process for manufacturing tablets for the sustained release of active principle(s) (2002-04-30),
2. 6375987 - Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix (2002-04-23),
3. 6312704 - Orally administrable composition capable of providing enhanced bioavailability when ingested (2001-11-06),
4. 6194005 - Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix (2001-02-27),
5. 6054136 - Orally administrable composition capable of providing enhanced (2000-04-25),

Title: Nabil Farah: Innovator in Pharmaceutical Manufacturing

Introduction

Nabil Farah is a notable inventor based in Lyons, France. He has made significant contributions to the field of pharmaceutical manufacturing, particularly in the development of sustained-release formulations. With a total of 5 patents to his name, Farah's work has had a considerable impact on the industry.

Latest Patents

Among his latest patents is a process for manufacturing tablets for the sustained release of active principle(s). This invention involves preparing a fluid oil-in-water emulsion, spraying the resulting emulsion on a powder mixture containing at least the active principle, and subjecting the treated powder to a compressing step to obtain tablets. Another significant patent is for the manufacture of pharmaceutical compositions with modified release of active principles comprising the matrix. These innovations showcase Farah's expertise in creating effective drug delivery systems.

Career Highlights

Throughout his career, Nabil Farah has worked with reputable companies, including Gattefosse S.A. His experience in the pharmaceutical industry has allowed him to refine his skills and contribute to advancements in drug formulation technologies.

Collaborations

Farah has collaborated with notable individuals in his field, including Joseph Joachim and Joel Denis. These partnerships have likely enriched his work and led to further innovations in pharmaceutical manufacturing.

Conclusion

Nabil Farah's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an innovator in drug formulation. His work continues to influence the development of effective pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…